ArticleGenes & genomics2023

Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway.

Liqiong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.